Abstract
Molecular epidemiology can be defined simply as the application of the techniques of molecular biology to the study of populations, with a particular focus on the investigation of disease. Molecular investigations, as we will see, have several aims and can contribute to the elucidation of disease causation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Auckley DH, Crowell RE, Heaphy ER, Stidley CA, Lechner JF, Gilliland FD, Belinsky SA (2001) Reduced DNA-dependent protein kinase activity is associated with lung cancer. Carcinogenesis 22(5):723–727
Bartsch H (2000) Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research. Mutat Res 462(2–3):255–279
Berwick M, Vineis P (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. JNCI 92(11):874–897
Berwick M, Matullo G, Vineis P (2002) Studies of DNA repair and human cancer: an update. In: Wilson SH, Suk WA (eds) Biomarkers of environmentally associated disease. Lewis Publishers, Boca Raton
Brennan P, Silman A (1992) Statistical methods for assessing observer variability in clinical measures. Br Med J 304:1491–1494
Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I — The analysis of case-control studies. IARC Scientific Publications No 32. International Agency for Research on Cancer, Lyon
Carmines EG, Zeller RA (1979) Reliability and validity assessment. Sage Publications, London
Cordon-Carlo C, Dalbagni G, Saez GT, Oliva MR, Zhang ZF, Rosai J, Reuter VE, Pellicer A (1994) p53 mutations in human bladder cancer: genotypic vs. phenotypic patterns. Int J Cancer 56:347–353
Denissenko MF, Pao A, Tang M, Pfeifer GP (1998) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274(5286):430–432
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. Br Med J 315(7121):1533–1537
Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen SC, Nichols PW, Skinner DG, Jones PA, Cote RJ (1994) Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331(19):1259–1264
Fletcher RH, Fletcher S, Wagner EH (1988) Clinical epidemiology — the essentials, 2nd edn. Williams and Wilkins, Baltimore
ISI Foundation(2004) DNA repair polymorphisms site. (http://perseus.isi.it/HuGe-Repair/HuGe-Repair.htm) Accessed June 18, 2004
Lowrance WW (2001) The promise of human genetic databases. Br Med J 322(7293):1009–1010
Phillips DH, Castegnaro M (1999) Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 14(3):301–315
Schulte P, Perera FP (eds) (1998) Molecular epidemiology: Principles and practices. Academic Press, New York
Shields PG, Harris CC (2000) Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol 18(11):2309–2315
Tang D, Phillips DH, Stampfer M, Mooney LA, Hsu Y, Cho S, Tsai WY, Ma J, Cole KJ, She MN, Perera FP (2001) Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res 61(18):6708–6712
Toniolo P, Boffetta P, Shuker D, Rothman N, Hulka B, Pearce N (1997) Application of biomarkers to cancer epidemiology. IARC Scientific Publications No 142. International Agency for Research on Cancer, Lyon
Veglia F, Matullo G, Vineis P (2003) Bulky DNA adducts and risk of cancer: a metaanalysis. Cancer Epidemiol Biomarkers Prev 12(2):157–160
Vineis P, Caporaso N, Cuzick J, Lang M, Malats N, Boffetta P (1999) Genetic susceptibility to cancer: metabolic polymorphisms. IARC Scientific Publication No 148. International Agency for Research on Cancer, Lyon
Vineis P, Veglia F, Benhamou Dorota Butkiewicz S, Cascorbi I, Clapper LM, Dolzan V, Haugen A, Hirvonen A, Ingelman-Sundberg M, Kihara M, Kiyohara C, Kremers P, Le Marchand L, Ohshima S, Pastorelli R, Rannug A, Romkes M, Schoket B, Shields P, Strange CR, Stucker I, Sugimura H, Garte S, Gaspari L, Taioli E (2003) CYP1A1T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. Int J Cancer 104(5):650–657
Wacholder S, Rothman N, Caporaso N (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 92:1151–1158
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Vineis, P., Matullo, G., Berwick, M. (2005). Molecular Epidemiology. In: Ahrens, W., Pigeot, I. (eds) Handbook of Epidemiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-26577-1_28
Download citation
DOI: https://doi.org/10.1007/978-3-540-26577-1_28
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-00566-7
Online ISBN: 978-3-540-26577-1
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)